...
首页> 外文期刊>Bioorganic and Medicinal Chemistry Letters >Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.
【24h】

Structure-activity relationships of pyrrole based S-nitrosoglutathione reductase inhibitors: pyrrole regioisomers and propionic acid replacement.

机译:基于吡咯的S-亚硝基谷胱甘肽还原酶抑制剂的结构活性关系:吡咯区域异构体和丙酸替代。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

S-Nitrosoglutathione reductase (GSNOR) is a member of the alcohol dehydrogenase family (ADH) that regulates the levels of S-nitrosothiols (SNOs) through catabolism of S-nitrosoglutathione (GSNO). GSNO and SNOs are implicated in the pathogenesis of many diseases including those in respiratory, cardiovascular, and gastrointestinal systems. The pyrrole based N6022 was recently identified as a potent, selective, reversible, and efficacious GSNOR inhibitor which is currently undergoing clinical development. We describe here the synthesis and structure-activity relationships (SAR) of novel pyrrole based analogues of N6022 focusing on scaffold modification and propionic acid replacement. We identified equally potent and novel GSNOR inhibitors having pyrrole regioisomers as scaffolds using a structure based approach.
机译:S-亚硝基谷胱甘肽还原酶(GSNOR)是酒精脱氢酶家族(ADH)的成员,该家族通过S-亚硝基谷胱甘肽(GSNO)的分解代谢来调节S-亚硝基硫醇(SNOs)的水平。 GSNO和SNO与许多疾病的发病机制有关,包括呼吸系统,心血管和胃肠系统疾病。基于吡咯的N6022最近被鉴定为有效,选择性,可逆和有效的GSNOR抑制剂,目前正在临床研究中。我们在这里描述了N6022的新型基于吡咯的类似物的合成和构效关系(SAR),重点关注支架修饰和丙酸替代。我们使用基于结构的方法鉴定了具有吡咯区域异构体作为支架的同等效力和新颖的GSNOR抑制剂。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号